SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001615774-16-007615
Filing Date
2016-10-13
Accepted
2016-10-13 16:41:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A s104324_sc13da.htm SC 13D/A 36574
  Complete submission text file 0001615774-16-007615.txt   37898
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Subject) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87827 | Film No.: 161935291
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1525 VOORHIES AVENUE BROOKLYN NY 11235
Business Address
Parnes Harold S (Filed by) CIK: 0001634060 (see all company filings)

Type: SC 13D/A